SNAI2 and prostate cancer: SNAI2 has been identified as a target gene of miR-203 in breast and prostate cancer [26–28], and we confirmed that mature miR-203 decreased the relative luciferase activity of the 3′-UTR reporter vectors by approximately 50-70% (Supplemental Figure 4A).